Add this topic to your myFT Digest for news straight to your inbox
Success of biosimilars in lowering prices will depend on decisions from powerful pharmacy benefit managers
As threats morph, the cultural objections to working with the government need to change too
US health insurer is facing dozens of complaints alleging it has not paid its bills
Complaint says acquiring claims tech company would give UnitedHealth access to rivals’ data
Appointment catapults pharma executive into leading role in US healthcare industry
Big threat to profits will come from rise of claims when deferred medical treatments resume
The fact that health insurers benefit in a pandemic while hospitals are on the brink is food for thought
Investors sense that in several years, earnings will be in peril
Ruling against UnitedHealth could force industry to cover illnesses such depression and addiction
US president expected to outline plans in speech to lower drug prices
Global bond sell-off pressures equity markets around the world
US stocks climb, with Macau casino stocks rallying on analyst upgrade
A complex, opaque and concentrated market could use a shake-up
Shares in health insurance group rise on takeover reports sending valuation to $60bn
Investors opt not to trust forecasts of Shinzo Abe victory after other polling snafus
Share prices outpace the market as groups focus on other areas of their businesses
International Edition